Skip to content
Recall Observatory FDA recall evidence

Drug product

fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL in 35 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1099-49

D-0551-2020

November 12, 2019

Class II

Product summary

Firm
QuVa Pharma, Inc.
Event
Event 84263
Status
Terminated
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-0551-2020

Official wording

Reason: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Code information: Lots: 10029934 Exp. 11/19/2019, 10029820 Exp. 11/18/2019, 10029872 Exp. 11/19/2019, 10029873 Exp. 11/19/2019, 10030868 Exp. 11/28/2019, 10030567 Exp. 11/28/2019, 10030892 Exp. 12/2/2019, 10030567 Exp. 11/28/2019, 10030568 Exp. 11/28/2019, 10030892 Exp. 12/2/2019, 10031210 Exp. 12/9/2019, 10031211 Exp. 12/9/2019, 10031209 Exp. 12/12/2019, 10031439 Exp. 12/15/2019, 10031700 Exp. 12/22/2019, 10031438 Exp. 12/15/2019, 10031766 Exp. 12/26/2019, 10032225 Exp.12/29/2019, 10032260 Exp. 12/30/2019, 10032343 Exp. 12/31/2019,

Distribution pattern: Nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate matter